News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
ESMO – Ipilimumab and nivolumab in unresected advanced Hepatocellular Carcinoma
Photo taken from ESMO/X
Jul 5, 2024, 02:27

ESMO – Ipilimumab and nivolumab in unresected advanced Hepatocellular Carcinoma

ESMO shared on X:

“Benefits reported for the combination of ipilimumab and nivolumab further expand alternative therapeutic options for patients with unresected advanced Hepatocellular Carcinoma.

Read the opinion piece by Angela Lamarca on ESMO Daily Reporter.”

Read further.
Source: ESMO/X

Angela Lamarca cancer ESMO hepatocellular carcinoma OncoDaily Oncology
Special Coverage
Blog
Feb 22, 2025, 04:33
SPCC announced the upcoming launch of the "Digital Oncology" book series
Blog
Feb 22, 2025, 04:29
Results from the SIOPE OCEAN project are out
Blog
Feb 22, 2025, 04:25
Empower families to face their cancer journey with strength and hope - Cancer Hope Network
Blog
Feb 22, 2025, 04:19
Secure your spot for the CCI4EU Online Course by ESO
Blog
Feb 22, 2025, 04:16
Manchester Cancer Research Centre will continue its leadership in early detection science following the renewal of ACED
Blog
Feb 22, 2025, 04:12
Citrus Oncology is part of the 14 startups selected for the 2025 CancerX Accelerator
Science
Feb 22, 2025, 04:08
Anticancer potential of NO-Donor Oxadiazole in malignant pleural mesothelioma - The Babak Lab
Blog
Feb 22, 2025, 03:56
Early bird registration deadline for the 15th CCI Europe Conference approaches
Blog
Feb 22, 2025, 03:52
Share Your MASCC Guidelines Experience
Insight
Feb 22, 2025, 03:44
George Vlachogiannis: Cutting cancer mortality in Canada by 50% by 2050 - can we get there?
Blog
Feb 22, 2025, 03:21
Brian Kim: Unsolicited advice to new PIs
Blog
Feb 22, 2025, 03:18
Christine Lovly: Why is NIH important?